Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)EBIATLeasesOther Gross PP&E AdjustmentsShares Issued
Ratios

Amicus Therapeutics (FOLD) Long-Term Debt Issuances (2016 - 2018)

Historic Long-Term Debt Issuances for Amicus Therapeutics (FOLD) over the last 7 years, with Q4 2018 value amounting to -$26000.0.

  • Amicus Therapeutics' Long-Term Debt Issuances changed N/A to -$26000.0 in Q4 2018 from the same period last year, while for Dec 2021 it was -$26000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $387.4 million for FY2023, which is N/A changed from last year.
  • Per Amicus Therapeutics' latest filing, its Long-Term Debt Issuances stood at -$26000.0 for Q4 2018.
  • In the past 5 years, Amicus Therapeutics' Long-Term Debt Issuances ranged from a high of $212.5 million in Q4 2016 and a low of -$26000.0 during Q4 2018
  • For the 3-year period, Amicus Therapeutics' Long-Term Debt Issuances averaged around $77.4 million, with its median value being $19.6 million (2014).
  • Within the past 5 years, the most significant YoY rise in Amicus Therapeutics' Long-Term Debt Issuances was 25004.46% (2014), while the steepest drop was 25004.46% (2014).
  • Quarter analysis of 3 years shows Amicus Therapeutics' Long-Term Debt Issuances stood at $19.6 million in 2014, then skyrocketed by 982.1% to $212.5 million in 2016, then tumbled by 100.01% to -$26000.0 in 2018.
  • Its last three reported values are -$26000.0 in Q4 2018, $212.5 million for Q4 2016, and $19.6 million during Q1 2014.